ATS GUIDELINES Bundle

Exercise-Induced Bronchoconstriction

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/528960

Contents of this Issue

Navigation

Page 5 of 9

Table 2. Second-line Medications for Exercise-induced Bronchoconstriction (EIB) a Generic (Brand) Dosage Form Dose Administer daily Inhaled corticosteroids See Table 3 Leukotriene modifiers Montelukast (Singulair ® ) 10 mg tablets 4 mg, 5 mg chewable tablets 4 mg oral granules packet 6-14 yrs old: 5 mg chewable tablet qHS ≥15 yrs old: 10 mg tablet qHS Zafirlukast (Accolate ® ) 10, 20 mg tablet 5-11 yrs old: 10 mg bid taken ≥1 h before or 2 h aer meals ≥12 yrs old: 20 mg bid taken ≥1 h before or 2 h aer meals Zileuton (Zyflo CR ® ) 600 mg tablet ≥12 yrs old: 1200 mg bid Administer 15 minutes prior to exercise Mast cell stabilizing agents Cromolyn (Intal ® ) MDI: 800 mcg/inh Nebulizer: 20 mg/2 mL ampule MDI: 2 inh given 15 minutes prior to exercise Nebulizer: 1 ampule given 15 minutes prior to exercise Nedocromil (Tilade ® ) MDI: 1.75 mg/inh ≥6 yr old: 2 inh given 15 minutes prior to exercise Anticholinergic agents Ipratropium (Atrovent HFA ® ) MDI: 17 mcg/inh 2 inh given 15 minutes prior to exercise Max dose: 12 inh/day a A second-line medication is administered if patients continue to have symptoms despite first-line medication. Treatment

Articles in this issue

view archives of ATS GUIDELINES Bundle - Exercise-Induced Bronchoconstriction